Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Dreno

Showing results (71-80 of 213) with videos related to

Pageof 22
Sort By:
JAAD Case Reports|April 7, 2016
Dramatic response of an inoperable Merkel cell carcinoma with imatinibCecile Frenard, Lucie Peuvrel, Anabelle Brocard, et al.
The European Journal of General Practice|August 21, 2014
Melanoma incidence and patient compliance in a targeted melanoma screening intervention. One-year follow-up in a large French cohort of high-risk patientsCédric Rat, Gaelle Quereux, Charlotte Grimault, et al.
Presse Medicale (Paris, France : 1983)|April 26, 2008
[Herpes serology for genital herpes]Jérôme Legoff, Michèle Aymard, Suzanne Braig, et al.
European Journal of Immunology|March 11, 2010
Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapyYann Godet, Juliette Desfrançois, Virginie Vignard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 23, 2023
Ultra-concentrated tri-acid complex serum as maintenance therapy in adult female acneCatherine Queille-Roussel, Caroline Le Floc'h, Guenaelle Le Dantec, et al.
Pediatric Dermatology|September 16, 2008
Infantile acne: a retrospective study of 16 casesMuriel Hello, Sorilla Prey, Christine Léauté-Labrèze, et al.
Cancer Immunology, Immunotherapy : CII|July 10, 2008
A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patientsYann Godet, Annabelle Bonnin, Yannik Guilloux, et al.
European Journal of Dermatology : EJD|June 28, 2016
Immunohistochemical markers of advanced basal cell carcinoma: CD56 is associated with a lack of response to vismodegibJean-Marie Castillo, Anne-Chantal Knol, Jean-Michel Nguyen, et al.
Journal of Drugs in Dermatology : JDD|July 8, 2017
Prospective Study of Pathogenesis of Atrophic Acne Scars and Role of Macular ErythemaJerry Tan, Valérie Bourdès, Robert Bissonnette, et al.
Journal of Medical Internet Research|April 15, 2018
Use of Smartphones for Early Detection of Melanoma: Systematic ReviewCédric Rat, Sandrine Hild, Julie Rault Sérandour, et al.
Pageof 22

Showing results (71-80 of 213) with videos related to

Sort By:
Pageof 22
JAAD Case Reports|April 7, 2016
Dramatic response of an inoperable Merkel cell carcinoma with imatinibCecile Frenard, Lucie Peuvrel, Anabelle Brocard, et al.
The European Journal of General Practice|August 21, 2014
Melanoma incidence and patient compliance in a targeted melanoma screening intervention. One-year follow-up in a large French cohort of high-risk patientsCédric Rat, Gaelle Quereux, Charlotte Grimault, et al.
Presse Medicale (Paris, France : 1983)|April 26, 2008
[Herpes serology for genital herpes]Jérôme Legoff, Michèle Aymard, Suzanne Braig, et al.
European Journal of Immunology|March 11, 2010
Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapyYann Godet, Juliette Desfrançois, Virginie Vignard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 23, 2023
Ultra-concentrated tri-acid complex serum as maintenance therapy in adult female acneCatherine Queille-Roussel, Caroline Le Floc'h, Guenaelle Le Dantec, et al.
Pediatric Dermatology|September 16, 2008
Infantile acne: a retrospective study of 16 casesMuriel Hello, Sorilla Prey, Christine Léauté-Labrèze, et al.
Cancer Immunology, Immunotherapy : CII|July 10, 2008
A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patientsYann Godet, Annabelle Bonnin, Yannik Guilloux, et al.
European Journal of Dermatology : EJD|June 28, 2016
Immunohistochemical markers of advanced basal cell carcinoma: CD56 is associated with a lack of response to vismodegibJean-Marie Castillo, Anne-Chantal Knol, Jean-Michel Nguyen, et al.
Journal of Drugs in Dermatology : JDD|July 8, 2017
Prospective Study of Pathogenesis of Atrophic Acne Scars and Role of Macular ErythemaJerry Tan, Valérie Bourdès, Robert Bissonnette, et al.
Journal of Medical Internet Research|April 15, 2018
Use of Smartphones for Early Detection of Melanoma: Systematic ReviewCédric Rat, Sandrine Hild, Julie Rault Sérandour, et al.
Pageof 22